Posted on 10 月 8, 202410/8/24
OpenAI’s new o1 Series models’ focus on “reasoning” and what it could mean to lifesciences brands and marketers
Posted on 5 月 13, 20245/13/24
Leveraging Generative AI in Brand Planning: Insights from Second Annual Pharmaceutical Brand Planning Survey
Posted on 5 月 12, 20245/12/24
Maximizing Sales Impact in a Hybrid World
Posted on 3 月 1, 20243/1/24
Future-Proofing Demands Proof: How Innovators Are Transforming Pharma Commercialization
Posted on 6 月 16, 20236/16/23
Digital Guide to Commercializing Complex Therapeutics
Posted on 4 月 27, 20234/27/23
The Necessity of Mapping the Tumor Journey for Oncology Marketers
Posted on 4 月 4, 20234/4/23
Achieving Digital Enlightenment in 2023 and Beyond
Posted on 3 月 30, 20233/30/23
Next Generation Brand Planning: Fueling Brand Plan Efficiency Through Seamless Integration
Posted on 1 月 20, 20231/20/23
Missed Connection or Meant to Be?
Posted on 8 月 18, 20228/18/22